Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Elranatamab-bcmm
Trade Name Elrexfio
Synonyms PF-06863135|PF06863135|PF 06863135
Drug Descriptions

Elrexfio (elranatamab-bcmm) is a bispecific antibody that binds to both TNFRSF17 (BCMA) and CD3, thereby crosslinking BCMA-expressing tumor cells and cytotoxic T-lymphocytes, potentially resulting in increased immune response against BCMA-expressing tumor cells (J Clin Oncol 39, no. 15_suppl (May 20, 2020) 8006-8006). Elrexfio (elranatamab-bcmm) is FDA -approved for use in patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy (FDA.gov).

DrugClasses CD3 Antibody 99 TNFRSF17 Antibody 20
CAS Registry Number NA
NCIT ID C146860

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carfilzomib + Elranatamab-bcmm Carfilzomib Elranatamab-bcmm 0 1
Cevostamab + Elranatamab-bcmm Cevostamab Elranatamab-bcmm 0 1
Daratumumab + Elranatamab-bcmm Daratumumab Elranatamab-bcmm 0 1
Daratumumab + Elranatamab-bcmm + Lenalidomide Daratumumab Elranatamab-bcmm Lenalidomide 0 1
Elranatamab-bcmm Elranatamab-bcmm 0 13
Elranatamab-bcmm + Iberdomide Elranatamab-bcmm Iberdomide 0 1
Elranatamab-bcmm + Nirogacestat Elranatamab-bcmm Nirogacestat 0 1


Additional content available in CKB BOOST